Company Description

LINDIS Biotech is to develop ektomun, an innovative immunotherapeutic for the treatment of small cell lung cancer, melanoma.

LINDIS Biotech was founded to develop ektomun, an innovative immunotherapeutic for the treatment of small cell lung cancer, melanoma and other neuroectodermal cancers that currently lack sufficient treatment options.